Navigation Links
Clinical Financial Services (CFS) Launches New Service to Streamline Clinical Trial Activation
Date:5/17/2011

PHILADELPHIA, May 17, 2011 /PRNewswire/ -- As part of its ongoing mission to provide comprehensive business and financial management solutions in support of clinical trials, Clinical Financial Services (CFS) is pleased to announce the launch of its newest offering, Site Activation Services. This revolutionary new service, which includes regulatory document collection and management as well as global investigator budget and contract management, will streamline and automate the trial activation process and minimize financial risk for clinical trial sponsors, CROs, and investigative sites.

Headed by an experienced team dedicated to managing the complex tasks required to activate investigator sites, CFS can accelerate clinical trial cycle times by maximizing the number of sites that are activated and "enrollment ready" when the enrollment phase of the trial begins.

  • By pre-populating regulatory and financial disclosure documents with data from an enterprise-wide proprietary database, CFS ensures the accuracy of site and investigator information, prevents redundancy and speeds the time it takes to complete this paperwork.
  • Through extensive audit capabilities, CFS ensures that financial disclosure information is compliant with 21CFR Part 54 and internal SOPs, consistent with Form FDA 1572 and aligned with aggregate spend payment data.
  • With a robust global legal network operating in more than 60 countries, CFS supports complex contract negotiations around the world.
  • By offering a technologically advanced project dashboard that is available 24/7, CFS offers unprecedented visibility into the status of every trial start-up document.

"With complicated regulatory documentation, tight timelines, and the newly passed Sunshine Act, proper business and financial management of clinical trials is more important than ever," says Greg Seminack, CFS President and Managing Partner. "Partnering w
'/>"/>

SOURCE Clinical Financial Services
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ACT Announces Oregon Health & Science University as Clinical Trial Site for its Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration
2. Jennerex to Present JX-594 Liver Cancer Clinical Data at American Society of Gene and Cell Therapy Meeting
3. Micell Technologies Reports Preclinical Data for MiStent™ Drug-Eluting Coronary Stent to be Presented at EuroPCR
4. Neuralstem Reports First Quarter Financial Results and Provides Business and Clinical Update
5. ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock
6. Adeonas Multiple Sclerosis Clinical Trial Receives $1,594,553 Grant
7. Clinical Site Services Expands to Provide Global Patient Enrollment Services to Rest-of-World
8. Optimer Pharmaceuticals and Clinical Investigators to Present Data at Upcoming Medical Meetings
9. Omnicare Clinical Research Acquired by Nautic Partners, LLC
10. Stanford and SanBio Announce a Clinical Trial of Cell Therapy for Stroke Disability
11. ACT Files European Clinical Trial Application for Phase 1/2 Study Using Embryonic Stem Cells to Treat Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... the transplant recipient,s immune system identifies the transplanted organ ... thought that T cells, the immune cells that mediate ... chemokines in order to migrate to the transplanted organ. ... Investigation , Fadi Lakkis and colleagues at the University ... of T cells is not required for migration. Instead, ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 The new ... Photonics21 at the association’s recent annual meeting drew ... EC Vice-President Neelie Kroes, who called the action “a ... and a stimulant to European innovation.” , The Board ... of the new Photonics PPP at its 29 April ...
(Date:5/17/2013)... , May 17, 2013  Cellular Biomedicine Group ... 50% enrollment of the total projected enrollment required ... safety and preliminary efficacy of the medical technology ... Knee Osteoarthritis (KOA). To date the trial has ... The Phase I open label clinical research ...
(Date:5/17/2013)... , May 17, 2013  Insero Health, Inc., ... needs in epilepsy and related neurological disorders, is today ... its lead compound INS001 in patients with drug-resistant epilepsy.  ... and Device Trials (AED) Xll meeting by Dr. ... and Chairman of Insero,s Scientific Advisory Board.  In this ...
Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2
... DRRX ) announced today that management is scheduled to present ... -- Needham & Company,s Biotechnology and Medical Technology Conference ... EDT. -- Leerink Swann,s Pain Roundtable Conference, on Monday, June ... Jefferies, 2nd Annual Healthcare Conference on Thursday, June 26th at ...
... June 5 BioTrends Research Group, Inc.,released its ... the management of psoriasis. This report is based ... US Dermatologists in April,2008., According to the ... their use of biologics for the treatment of ...
... BSX ) is scheduled to participate in Goldman ... in Dana Point,CA., Jim Tobin, Boston Scientific Chief ... followed by a 25-minute question and,answer session on Wednesday, ... live webcast of Mr. Tobin,s remarks will be available ...
Cached Biology Technology:Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis 2
(Date:5/16/2013)... A scientist has discovered an ancient extinct creature with ... it in honour of his favourite movie star. ... Kooteninchela deppi (pronounced Koo-ten-ee-che-la depp-eye), which is a ... the actor Johnny Depp for his starring role as ... named Edward, an unfinished creation, who has scissors for ...
(Date:5/16/2013)... outside the bone marrow in the liver, the ... now show that a specific type of immune cell ... Balanced hematopoiesis is essential for the function of the ... in the liver and the spleen. Later the process ... normally serves as the sole source of blood cells ...
(Date:5/16/2013)... the world are meeting next week in Toronto. ... the latest in research findings about the brain, ... the disorders that affect them., "Canada is a ... showcase the best of neuroscience research done here ... of the Canadian Association for Neuroscience. He also ...
Breaking Biology News(10 mins):Actor Johnny Depp immortalized in ancient fossil find 2Herpes infections: Natural killer cells activate hematopoiesis 27th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2
... Academy of Sciences will launch the most comprehensive scientific ... terrestrial and marine life forms from the tops of ... They will be joined by colleagues from the University ... National Museum and the Philippines Bureau of Fisheries and ...
... Bethesda, MD FASEB MARC (Minority Access to ... for The Endocrine Society,s 93rd Annual Meeting and Expo ... awards are meant to promote the entry of underrepresented ... the basic science community and to encourage the participation ...
... RUSTON, La. Dr. Yuri Lvov, professor of chemistry ... at Louisiana Tech University, recently led a symposium at ... discussing his application of a more eco-friendly and cost-effective ... properties of plastics, paints and other synthetic composites. ...
Cached Biology News:California Academy of Sciences launches scientific expedition to the Philippines 2California Academy of Sciences launches scientific expedition to the Philippines 3California Academy of Sciences launches scientific expedition to the Philippines 4California Academy of Sciences launches scientific expedition to the Philippines 5Louisiana Tech researcher presents on eco-friendly nanotechnology at national conference 2
Cytofix Buffer 100 mls...
Perm/Wash Buffer 250 Tests...
The BD PhosFlow Fix Buffer I can be used for the simultaneous fixation and permeabilization of cells prior to intracellular staining. Applications: Intracellular Staining (Flow) Storage Temperature:...
Request Info...
Biology Products: